Efficacy of hypertonic saline dextran (HSD) in patients with traumatic hypotension: meta-analysis of individual patient data.
Wade
C
C
Medisan Pharmaceuticals AB, Uppsala, Sweden.
Grady
J
J
Kramer
G
G
D001794:Blood Pressure; D001810:Blood Volume; D003911:Dextrans / Q000008:administration & dosage / Q000627:therapeutic use*; D005440:Fluid Therapy; D006801:Humans; D007022:Hypotension / Q000209:etiology / Q000628:therapy*; D007262:Infusions, Intravenous; D016017:Odds Ratio; D010351:Patient Discharge; D010952:Plasma Substitutes / Q000008:administration & dosage / Q000627:therapeutic use*; D012462:Saline Solution, Hypertonic / Q000008:administration & dosage / Q000627:therapeutic use*; D012769:Shock / Q000628:therapy; D012964:Sodium / Q000097:blood; D015996:Survival Rate; D016896:Treatment Outcome; D014949:Wounds, Nonpenetrating / Q000150:complications*; D014950:Wounds, Penetrating / Q000150:complications*
D003911:Dextrans; D010952:Plasma Substitutes; D012462:Saline Solution, Hypertonic; D012964:Sodium